hek blue nfкb reporter cells Search Results


human monoclonal nfкb p65 antibody  (ScyTek Inc)
90
ScyTek Inc human monoclonal nfкb p65 antibody
Human Monoclonal Nfкb P65 Antibody, supplied by ScyTek Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hek+blue+nf%D0%BAb+reporter+cells/human+monoclonal+nf%D0%BAb+p65+antibody/pmc07900636-60-13-18
Average 90 stars, based on 1 article reviews
human monoclonal nfкb p65 antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
purified mouse anti-nfкβ p65  (Becton Dickinson)
90
Becton Dickinson purified mouse anti-nfкβ p65
Purified Mouse Anti Nfкβ P65, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hek+blue+nf%D0%BAb+reporter+cells/purified+mouse+anti+nf%D0%BA%CE%B2+p65/pm31931300-79-16-23
Average 90 stars, based on 1 article reviews
purified mouse anti-nfкβ p65 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
nfкb reporter plasmid  (Addgene inc)
93
Addgene inc nfкb reporter plasmid
Nfкb Reporter Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hek+blue+nf%D0%BAb+reporter+cells/Construct+32+-+NFKBRp_mKate2_2xNLS_p2a-puroR+(Plasmid+%2382024)/pm41721598-333-1-7
Average 93 stars, based on 1 article reviews
nfкb reporter plasmid - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
anti nfкb p65  (Santa Cruz Biotechnology)
96
Santa Cruz Biotechnology anti nfкb p65
Pam3CSK4 exacerbated learning-memory dysfunction and stimulated the TLR2/NFκB signaling pathway and IL-10 secretion in HIBD rats. a Diagram illustrating the experimental protocols of treatments and tests used in the rats. b - c The escape latencies and path lengths to reach the visible platform on the first day of the Morris water maze test for the HIBD and Pam3CSK4 groups. d The escape latencies to reach the visible platform on the 2 nd through the 5 th days of the Morris water maze test for the Pam3CSK4-treated and HIBD groups. e The duration spent in the hidden platform quadrant by the Pam3CSK4-treated and HIBD groups. n = 20 in each group. f - g The Pam3CSK4-induced mRNA and protein expression levels of TLR2, NFκB <t>P65</t> and Bax in the brains of 4-week-old rats. n = 5 in each group. h The quantifications of WB signal in G. i IL-10 release in the brains of 4-week-old rats in HIBD and Pam3CSK4 groups. n = 6 in each group. # P < 0.05 vs. the HIBD group
Anti Nfкb P65, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hek+blue+nf%D0%BAb+reporter+cells/NF%CE%BAB+p65+Antibody/pmc04609057-173-5-8
Average 96 stars, based on 1 article reviews
anti nfкb p65 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


Pam3CSK4 exacerbated learning-memory dysfunction and stimulated the TLR2/NFκB signaling pathway and IL-10 secretion in HIBD rats. a Diagram illustrating the experimental protocols of treatments and tests used in the rats. b - c The escape latencies and path lengths to reach the visible platform on the first day of the Morris water maze test for the HIBD and Pam3CSK4 groups. d The escape latencies to reach the visible platform on the 2 nd through the 5 th days of the Morris water maze test for the Pam3CSK4-treated and HIBD groups. e The duration spent in the hidden platform quadrant by the Pam3CSK4-treated and HIBD groups. n = 20 in each group. f - g The Pam3CSK4-induced mRNA and protein expression levels of TLR2, NFκB P65 and Bax in the brains of 4-week-old rats. n = 5 in each group. h The quantifications of WB signal in G. i IL-10 release in the brains of 4-week-old rats in HIBD and Pam3CSK4 groups. n = 6 in each group. # P < 0.05 vs. the HIBD group

Journal: Molecular Brain

Article Title: Mesenchymal stem cells suppress neuronal apoptosis and decrease IL-10 release via the TLR2/NFκB pathway in rats with hypoxic-ischemic brain damage

doi: 10.1186/s13041-015-0157-3

Figure Lengend Snippet: Pam3CSK4 exacerbated learning-memory dysfunction and stimulated the TLR2/NFκB signaling pathway and IL-10 secretion in HIBD rats. a Diagram illustrating the experimental protocols of treatments and tests used in the rats. b - c The escape latencies and path lengths to reach the visible platform on the first day of the Morris water maze test for the HIBD and Pam3CSK4 groups. d The escape latencies to reach the visible platform on the 2 nd through the 5 th days of the Morris water maze test for the Pam3CSK4-treated and HIBD groups. e The duration spent in the hidden platform quadrant by the Pam3CSK4-treated and HIBD groups. n = 20 in each group. f - g The Pam3CSK4-induced mRNA and protein expression levels of TLR2, NFκB P65 and Bax in the brains of 4-week-old rats. n = 5 in each group. h The quantifications of WB signal in G. i IL-10 release in the brains of 4-week-old rats in HIBD and Pam3CSK4 groups. n = 6 in each group. # P < 0.05 vs. the HIBD group

Article Snippet: The anti-TLR2 (1:1000, Abcam, ab13855), anti-NFкB P65 (1:500, Santa Cruz, sc-8008), anti-Bax (1:500, Santa Cruz, sc-7480) and anti-β-actin primary antibodies (1:500, Santa Cruz, sc-130065) were incubated at 4 °C overnight.

Techniques: Expressing

Co-culturing OGD-injured PC12 cells with MSCs decreased the expression of TLR2, NFκB, Bax and IL-10. a - b The mRNA and protein expression levels of TLR2 in OGD-injured PC12 cells in the presence or absence of MSCs. n = 6 in each group. c The quantifications of WB signal in b . d - e The mRNA and protein expression levels of NFκB P65 in OGD-injured PC12 cells in the presence or absence of MSCs. n = 6 in each group. f The quantifications of WB signal in e . g - h The mRNA and protein expression levels of Bax in OGD-injured PC12 cells in the presence or absence of MSCs. n = 6 in each group. i The quantifications of WB signal in h . j The concentrations of IL-10 released into the culture media were measured in the control, OGD and OGD + MSCs groups via ELISA. n = 6 in each group. # P < 0.05 vs. the control PC12 cells; & P < 0.05 vs. the OGD-injured PC12 cells

Journal: Molecular Brain

Article Title: Mesenchymal stem cells suppress neuronal apoptosis and decrease IL-10 release via the TLR2/NFκB pathway in rats with hypoxic-ischemic brain damage

doi: 10.1186/s13041-015-0157-3

Figure Lengend Snippet: Co-culturing OGD-injured PC12 cells with MSCs decreased the expression of TLR2, NFκB, Bax and IL-10. a - b The mRNA and protein expression levels of TLR2 in OGD-injured PC12 cells in the presence or absence of MSCs. n = 6 in each group. c The quantifications of WB signal in b . d - e The mRNA and protein expression levels of NFκB P65 in OGD-injured PC12 cells in the presence or absence of MSCs. n = 6 in each group. f The quantifications of WB signal in e . g - h The mRNA and protein expression levels of Bax in OGD-injured PC12 cells in the presence or absence of MSCs. n = 6 in each group. i The quantifications of WB signal in h . j The concentrations of IL-10 released into the culture media were measured in the control, OGD and OGD + MSCs groups via ELISA. n = 6 in each group. # P < 0.05 vs. the control PC12 cells; & P < 0.05 vs. the OGD-injured PC12 cells

Article Snippet: The anti-TLR2 (1:1000, Abcam, ab13855), anti-NFкB P65 (1:500, Santa Cruz, sc-8008), anti-Bax (1:500, Santa Cruz, sc-7480) and anti-β-actin primary antibodies (1:500, Santa Cruz, sc-130065) were incubated at 4 °C overnight.

Techniques: Expressing, Control, Enzyme-linked Immunosorbent Assay

MSCs modulated the TLR2/NFκB signaling pathway and suppressed the apoptosis of OGD-injured PC12 cells and the secretion of IL-10. a Diagram illustrating the experimental protocols of the treatments and tests for PC12 cells. b - c The TLR2 mRNA and protein expression levels in co-cultures of MSCs with OGD-injured PC12 cells that received Pam3CSK4 or Ad-siTLR2 treatment. n = 6 in each group. d The quantifications of WB signal in c . e - f The mRNA and protein expression levels of NFκB P65 in co-cultures of MSCs with OGD-injured PC12 cells that were treated with Pam3CSK4 or Ad-siTLR2. n = 6 in each group. g The quantifications of WB signal in f . h - i The changes in the mRNA and protein expression levels of Bax in co-cultures of MSCs with OGD-injured PC12 cells that were treated with Pam3CSK4 or Ad-siTLR2. n = 6 in each group. j The quantifications of WB signal in i . k The changes in IL-10 release in co-cultures of MSCs with OGD-injured PC12 cells that received Pam3CSK4 or Ad-siTLR2 treatment. n = 6 in each group. # P < 0.05 vs. OGD-injured PC12 cells that were treated with Pam3CSK4 or Ad-siTLR2

Journal: Molecular Brain

Article Title: Mesenchymal stem cells suppress neuronal apoptosis and decrease IL-10 release via the TLR2/NFκB pathway in rats with hypoxic-ischemic brain damage

doi: 10.1186/s13041-015-0157-3

Figure Lengend Snippet: MSCs modulated the TLR2/NFκB signaling pathway and suppressed the apoptosis of OGD-injured PC12 cells and the secretion of IL-10. a Diagram illustrating the experimental protocols of the treatments and tests for PC12 cells. b - c The TLR2 mRNA and protein expression levels in co-cultures of MSCs with OGD-injured PC12 cells that received Pam3CSK4 or Ad-siTLR2 treatment. n = 6 in each group. d The quantifications of WB signal in c . e - f The mRNA and protein expression levels of NFκB P65 in co-cultures of MSCs with OGD-injured PC12 cells that were treated with Pam3CSK4 or Ad-siTLR2. n = 6 in each group. g The quantifications of WB signal in f . h - i The changes in the mRNA and protein expression levels of Bax in co-cultures of MSCs with OGD-injured PC12 cells that were treated with Pam3CSK4 or Ad-siTLR2. n = 6 in each group. j The quantifications of WB signal in i . k The changes in IL-10 release in co-cultures of MSCs with OGD-injured PC12 cells that received Pam3CSK4 or Ad-siTLR2 treatment. n = 6 in each group. # P < 0.05 vs. OGD-injured PC12 cells that were treated with Pam3CSK4 or Ad-siTLR2

Article Snippet: The anti-TLR2 (1:1000, Abcam, ab13855), anti-NFкB P65 (1:500, Santa Cruz, sc-8008), anti-Bax (1:500, Santa Cruz, sc-7480) and anti-β-actin primary antibodies (1:500, Santa Cruz, sc-130065) were incubated at 4 °C overnight.

Techniques: Expressing

Primers of the target genes used for real-time PCR

Journal: Molecular Brain

Article Title: Mesenchymal stem cells suppress neuronal apoptosis and decrease IL-10 release via the TLR2/NFκB pathway in rats with hypoxic-ischemic brain damage

doi: 10.1186/s13041-015-0157-3

Figure Lengend Snippet: Primers of the target genes used for real-time PCR

Article Snippet: The anti-TLR2 (1:1000, Abcam, ab13855), anti-NFкB P65 (1:500, Santa Cruz, sc-8008), anti-Bax (1:500, Santa Cruz, sc-7480) and anti-β-actin primary antibodies (1:500, Santa Cruz, sc-130065) were incubated at 4 °C overnight.

Techniques: